ICD-10-CM Code R97

Abnormal tumor markers

Version 2020 Non-Billable Code No Valid Principal Dx

Not Valid for Submission

R97 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of abnormal tumor markers. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions.

ICD-10:R97
Short Description:Abnormal tumor markers
Long Description:Abnormal tumor markers

Consider the following ICD-10 codes with a higher level of specificity:

  • R97.0 - Elevated carcinoembryonic antigen [CEA]
  • R97.1 - Elevated cancer antigen 125 [CA 125]
  • R97.2 - Elevated prostate specific antigen [PSA]
  • R97.20 - Elevated prostate specific antigen [PSA]
  • R97.21 - Rising PSA following treatment for malignant neoplasm of prostate
  • R97.8 - Other abnormal tumor markers

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code R97:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Elevated tumor associated antigens TAA
  • Elevated tumor specific antigens TSA

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal tumor markers (R97)
      • Abnormal tumor markers (R97)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020